152 related articles for article (PubMed ID: 17073223)
1. Cost effectiveness analysis of smoking cessation interventions.
Shearer J; Shanahan M
Aust N Z J Public Health; 2006 Oct; 30(5):428-34. PubMed ID: 17073223
[TBL] [Abstract][Full Text] [Related]
2. Cost effectiveness of varenicline in Belgium, compared with bupropion, nicotine replacement therapy, brief counselling and unaided smoking cessation: a BENESCO Markov cost-effectiveness analysis.
Annemans L; Nackaerts K; Bartsch P; Prignot J; Marbaix S
Clin Drug Investig; 2009; 29(10):655-65. PubMed ID: 19715382
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of face-to-face smoking cessation interventions: a dynamic modeling study.
Feenstra TL; Hamberg-van Reenen HH; Hoogenveen RT; Rutten-van Mölken MP
Value Health; 2005; 8(3):178-90. PubMed ID: 15877590
[TBL] [Abstract][Full Text] [Related]
4. Protocol for the Proactive Or Reactive Telephone Smoking CeSsation Support (PORTSSS) trial.
Coleman T; McEwen A; Bauld L; Ferguson J; Lorgelly P; Lewis S
Trials; 2009 Apr; 10():26. PubMed ID: 19400961
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness analysis of clinical smoking cessation interventions in Thailand.
Tosanguan J; Chaiyakunapruk N
Addiction; 2016 Feb; 111(2):340-50. PubMed ID: 26360507
[TBL] [Abstract][Full Text] [Related]
6. Cost-effective primary care-based strategies to improve smoking cessation: more value for money.
Salize HJ; Merkel S; Reinhard I; Twardella D; Mann K; Brenner H
Arch Intern Med; 2009 Feb; 169(3):230-5; discussion 235-6. PubMed ID: 19204212
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of pharmacological interventions for smoking cessation: a literature review and a decision analytic analysis.
Song F; Raftery J; Aveyard P; Hyde C; Barton P; Woolacott N
Med Decis Making; 2002; 22(5 Suppl):S26-37. PubMed ID: 12369228
[TBL] [Abstract][Full Text] [Related]
8. Costs and benefits of smoking cessation aids: making a case for public reimbursement of nicotine replacement therapy in Australia.
Bertram MY; Lim SS; Wallace AL; Vos T
Tob Control; 2007 Aug; 16(4):255-60. PubMed ID: 17652241
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness analysis of the first-line therapies for nicotine dependence.
Cornuz J; Pinget C; Gilbert A; Paccaud F
Eur J Clin Pharmacol; 2003 Jul; 59(3):201-6. PubMed ID: 12759795
[TBL] [Abstract][Full Text] [Related]
10. Smoking cessation in severe mental ill health: what works? an updated systematic review and meta-analysis.
Peckham E; Brabyn S; Cook L; Tew G; Gilbody S
BMC Psychiatry; 2017 Jul; 17(1):252. PubMed ID: 28705244
[TBL] [Abstract][Full Text] [Related]
11. Smoking cessation interventions for smokers with current or past depression.
van der Meer RM; Willemsen MC; Smit F; Cuijpers P
Cochrane Database Syst Rev; 2013 Aug; (8):CD006102. PubMed ID: 23963776
[TBL] [Abstract][Full Text] [Related]
12. [Economic evaluation of pharmacotherapies for smoking cessation].
Antoñanzas F; Portillo F
Gac Sanit; 2003; 17(5):393-403. PubMed ID: 14599422
[TBL] [Abstract][Full Text] [Related]
13. Smoking cessation interventions in clinical practice.
Cornuz J
Eur J Vasc Endovasc Surg; 2007 Oct; 34(4):397-404. PubMed ID: 17681834
[TBL] [Abstract][Full Text] [Related]
14. Varenicline in the management of smoking cessation: a single technology appraisal.
Hind D; Tappenden P; Peters J; Kenjegalieva K
Health Technol Assess; 2009 Sep; 13 Suppl 2():9-13. PubMed ID: 19804684
[TBL] [Abstract][Full Text] [Related]
15. Which is the best primary medication for long-term smoking cessation--nicotine replacement therapy, bupropion or varenicline?
Doggrell SA
Expert Opin Pharmacother; 2007 Dec; 8(17):2903-15. PubMed ID: 18001252
[TBL] [Abstract][Full Text] [Related]
16. The effectiveness and cost effectiveness of telephone counselling and the nicotine patch in a state tobacco quitline.
Hollis JF; McAfee TA; Fellows JL; Zbikowski SM; Stark M; Riedlinger K
Tob Control; 2007 Dec; 16 Suppl 1(Suppl 1):i53-9. PubMed ID: 18048633
[TBL] [Abstract][Full Text] [Related]
17. Crossing borders: factors affecting differences in cost-effectiveness of smoking cessation interventions between European countries.
Vemer P; Rutten-van Mölken MP
Value Health; 2010; 13(2):230-41. PubMed ID: 19804435
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of pharmacotherapies for nicotine dependence in primary care settings: a multinational comparison.
Cornuz J; Gilbert A; Pinget C; McDonald P; Slama K; Salto E; Paccaud F
Tob Control; 2006 Jun; 15(3):152-9. PubMed ID: 16728744
[TBL] [Abstract][Full Text] [Related]
19. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC
J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of tobacco control policies in Vietnam: the case of personal smoking cessation support.
Higashi H; Barendregt JJ
Addiction; 2012 Mar; 107(3):658-70. PubMed ID: 21883602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
